Wood Claire L, Soucek Ondrej, Wong Sze C, Zaman Farasat, Farquharson Colin, Savendahl Lars, Ahmed S Faisal
Division of Developmental BiologyRoslin Institute, University of Edinburgh, Edinburgh, UK.
Department of Paediatrics2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
J Endocrinol. 2018 Jan;236(1):R69-R91. doi: 10.1530/JOE-17-0361. Epub 2017 Oct 19.
Glucocorticoids (GCs) are effective for the treatment of many chronic conditions, but their use is associated with frequent and wide-ranging adverse effects including osteoporosis and growth retardation. The mechanisms that underlie the undesirable effects of GCs on skeletal development are unclear, and there is no proven effective treatment to combat them. An model that investigates the development and progression of GC-induced changes in bone is, therefore, important and a well-characterized pre-clinical model is vital for the evaluation of new interventions. Currently, there is no established animal model to investigate GC effects on skeletal development and there are pros and cons to consider with the different protocols used to induce osteoporosis and growth retardation. This review will summarize the literature and highlight the models and techniques employed in experimental studies to date.
糖皮质激素(GCs)对许多慢性病的治疗有效,但使用它们会带来频繁且广泛的不良反应,包括骨质疏松和生长发育迟缓。GCs对骨骼发育产生不良影响的机制尚不清楚,且尚无经证实有效的治疗方法来对抗这些影响。因此,一个研究GC诱导的骨骼变化的发生和发展的模型很重要,一个特征明确的临床前模型对于评估新的干预措施至关重要。目前,尚无用于研究GC对骨骼发育影响的成熟动物模型,且用于诱导骨质疏松和生长发育迟缓的不同方案各有优缺点。本综述将总结文献,并重点介绍迄今为止实验研究中使用的模型和技术。